Aptevo Therapeutics Inc.
APVO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $17 | $23 | $45 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $3 | $4 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $4 |
| Total Curr. Assets | $11 | $19 | $27 | $53 |
| Property Plant & Equip (Net) | $5 | $6 | $7 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $5 | $6 | $7 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $16 | $25 | $34 | $57 |
| Liabilities | – | – | – | – |
| Payables | $3 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $2 | $12 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $7 | $7 | $23 |
| Total Curr. Liab. | $6 | $7 | $9 | $35 |
| LT Debt | $5 | $5 | $8 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $16 |
| Total NC Liab. | $5 | $5 | $8 | $21 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $6 | $1 |
| Total Liabilities | $11 | $13 | $16 | $55 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$248 | -$223 | -$206 | -$214 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $252 | $236 | $224 | $215 |
| Total Equity | $5 | $12 | $18 | $1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $16 | $25 | $34 | $57 |
| Net Debt | -$4 | -$12 | -$13 | -$28 |